Northwestern Mutual Investment Management Company’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.96M	Buy	22,483 +175	+0.8%	+$23.2K	0.04%	168
2025 Q4	$3.16M	Buy	22,308 +201	+0.9%	+$29.1K	0.04%	151
2025 Q3	$3.1M	Buy	22,107 +10	+0%	+$1.35K	0.04%	159
2025 Q2	$2.78M	Sell	22,097 -72	-0.3%	-$8.26K	0.04%	167
2025 Q1	$2.45M	Sell	22,169 -333	-1%	-$42.2K	0.04%	180
2024 Q4	$3.07M	Buy	22,502 +99	+0.4%	+$12.2K	0.07%	130
2024 Q3	$2.58M	Sell	22,403 -59	-0.3%	-$8.09K	0.06%	170
2024 Q2	$3.09M	Buy	22,462 +267	+1%	+$36.6K	0.08%	117
2024 Q1	$3.06M	Buy	22,195 +337	+2%	+$46K	0.08%	123
2023 Q4	$2.88M	Buy	21,858 +200	+0.9%	+$23K	0.08%	125
2023 Q3	$2.44M	Sell	21,658 -27	-0.1%	-$2.84K	0.07%	127
2023 Q2	$2.04M	Buy	21,685 +256	+1%	+$25K	0.05%	164
2023 Q1	$2.17M	Buy	21,429 +12,532	+141%	+$1.3M	0.06%	137
2022 Q4	$1.06M	Sell	8,897 -4,915	-36%	-$576K	0.03%	229
2022 Q3	$1.47M	Sell	13,812 -2,186	-14%	-$222K	0.04%	182
2022 Q2	$1.56M	Buy	15,998 +242	+2%	+$22.3K	0.04%	211
2022 Q1	$1.48M	Buy	15,756 +30	+0.2%	+$2.54K	0.03%	287
2021 Q4	$1.34M	Buy	15,726 +91	+0.6%	+$8.37K	0.03%	383
2021 Q3	$1.5M	Sell	15,635 -111	-0.7%	-$10.5K	0.03%	297
2021 Q2	$1.53M	Buy	15,746 +136	+0.9%	+$13K	0.03%	290
2021 Q1	$1.52M	Buy	+15,610	New	+$1.64M	0.03%	280